drug plans Page 28

Keyword: drug plans

453 results found

Competitive total rewards programs are a critical component of Canadian organizations’ human resources and corporate strategy, according to a new survey by WorldatWork. The survey, which polled 150 Canadian employers in February, found 96 per cent offer drug, dental, life insurance/accidental death and dismemberment, long-term disability and employee assistance programs. Additionally, 93 per cent of […]

  • By: Staff
  • May 20, 2020 November 24, 2020
  • 15:15
Pharmacogenetic testing’s place in long-term disability programs

Plan sponsors and insurers are increasingly wading into the waters of pharmacogenetic testing by offering the service to employees making long-term disability claims. In 2017, Sun Life partnered with the Centre for Addiction and Mental Health for a pilot project that offered pharmacogenetic testing to plan members on disability leave due to a mental-health condition. […]

Coronavirus could reduce employer health-care costs, finds analysis

The coronavirus pandemic could reduce employer health-care costs by as much as four per cent in 2020 as medical care for non-infected patients has declined, according to a new analysis by Willis Towers Watson. The analysis of large, self-funded U.S.-based employers is an update to a similar study conducted in March that projected employer costs […]

  • By: Staff
  • May 4, 2020 November 12, 2020
  • 08:45
Green Shield Canada, PocketPills partner on virtual pharmacy access

Green Shield Canada is partnering with digital pharmacy PocketPills on a virtual pharmacy app for its group benefits plans. Plan members will be able to chat with a pharmacist, refill existing prescriptions through the app and have their medications delivered to their homes for free. The drugs come pre-sorted into packages by dosage and time, […]

  • By: Staff
  • April 30, 2020 November 12, 2020
  • 08:30
Drug plan considerations during the coronavirus pandemic

With providers of dental and paramedical services closed, many aspects of the benefits plans are seeing reduced use. But drug plan spending is continuing unabated — and experts say new concerns are coming up during the crisis. Plan sponsors that have implemented 90-day supplies as a cost-control measure may have to see if their plan can be adapted during […]

Manulife Financial Corp. is lending a hand to group benefits plan sponsors in light of the tight financial situation many businesses are in due to the coronavirus pandemic. The insurer is providing certain premium relief for all group benefits plan sponsors with an insured non-refund accounted benefits plan with Manulife. For the month of May, dental […]

  • By: Staff
  • April 20, 2020 March 24, 2021
  • 08:30
Canada Life cutting group health premiums to support Canadians, SMEs

The Canada Life Assurance Co. is cutting its health insurance premiums for its employer-sponsored benefits plans to support small- and medium-sized businesses facing hardship as a result of the coronavirus pandemic. “We recognize that many businesses are challenged right now and we are wholeheartedly committed to supporting them however we can,” said Jeff Macoun, president and […]

  • By: Staff
  • April 17, 2020 November 12, 2020
  • 09:05
Specialty drug usage, traditional drug costs drive small rise in 2019 spending: report

Private drug plans saw a slight uptick in costs in 2019 due to the increased use of specialty drugs and higher price points for traditional medications, according to Express Scripts Canada’s annual drug trends report. The report found private drug plan spending per claimant increased one per cent over 2018’s figures. Plans’ annual spend per claimant on […]

  • By: Staff
  • April 14, 2020 September 15, 2022
  • 10:00
Number of staff working remotely, part time up 415%: survey

Several weeks into the coronavirus pandemic, the U.S. has seen a 415 per cent increase in the percentage of employees working remotely or part time, according to a new survey by WorldatWork. The survey, which polled more than 1,500 total rewards and human resources professionals in the U.S., also found 37 per cent of organizations are providing […]

  • By: Staff
  • April 13, 2020 November 12, 2020
  • 15:15
Global sales of mental-health drugs could hit US$40B by 2025 due to coronavirus

The mental-health repercussions of the coronavirus could see global sales of psychiatric drugs increase to more than US$40 billion by 2025, according to data and analytics company GlobalData. Global sales for drugs to treat mental-health disorders such as depression, anxiety and obsessive compulsive disorder are expected to reach US$27.4 billion in 2020, an increase of US$717 […]

  • By: Staff
  • April 7, 2020 November 12, 2020
  • 15:00